Post-COVID changes in lung function 6 months after veno-venous extracorporeal membrane oxygenation: a prospective observational clinical trial
BackgroundSevere coronavirus disease 2019 (COVID-19) may require veno-venous extracorporeal membrane oxygenation (V-V ECMO). While V-V ECMO is offered in severe lung injury to COVID-19, long-term respiratory follow-up in these patients is missing. Therefore, we aimed at providing comprehensive data...
Main Authors: | Alexandra Pálfi, Ádám L. Balogh, Gabriella Polónyi, Domonkos Schulcz, Éva Zöllei, Gábor Bari, Gergely H. Fodor, Kristóf Baráth, Attila Somfay, Ferenc Peták, Barna Babik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1288679/full |
Similar Items
-
Efficacy of Marker-Based Motion Capture for Respiratory Cycle Measurement: A Comparison with Spirometry
by: Natalia D. Shamantseva, et al.
Published: (2023-12-01) -
Effect of somatotypes on lung volumes, capacities and respiratory impedance: A pilot study
by: Kumar Nischay Jaiswal, et al.
Published: (2024-01-01) -
Pulmonary function and medication effect in mild-stage subjects with Parkinson's disease
by: Renata Terra de Oliveira, et al.
Published: (2022-12-01) -
Physiological adaptations during weaning from veno-venous extracorporeal membrane oxygenation
by: Patrick Duncan Collins, et al.
Published: (2023-02-01) -
Outcomes of patients with COVID-19 supported by venovenous extracorporeal membrane oxygenation for greater than 90 daysCentral MessagePerspective
by: David R. Stern, MD, et al.
Published: (2023-12-01)